Company intelligence / Profile preview

Taiwan Genomic Industry Alliance

Taipei, Taipei City, Taiwantgia.net ↗

Ownership: Private
Development stage: Other

Overview

TGIA operates the most advanced next-generation and third-generation high-throughput industrial-grade sequencing laboratory in Taiwan. It has built a comprehensive database of rare disease-related genetic variants, cancer variants, and phenotypes specific to Asian populations. The company collaborates with medical centers and academic institutions to accelerate precision medicine adoption in hereditary/rare disease diagnostics as well as cancer genetics

Therapeutic areas: Infectious DiseasesRare DiseasesImmunologyOncology
Modalities: Next-generation sequencingThird-generation sequencing
Industry: Molecular Diagnostics

Partnerships

National Health Research Institutes (NHRI)medical centers across Asia-Pacific region

Beyond the preview

Go deeper on Taiwan Genomic Industry Alliance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taiwan Genomic Industry Alliance.

Explore the full profile